William Koltun

2.9k total citations
41 papers, 1.6k citations indexed

About

William Koltun is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Epidemiology. According to data from OpenAlex, William Koltun has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Genetics and 13 papers in Epidemiology. Recurrent topics in William Koltun's work include Menopause: Health Impacts and Treatments (15 papers), Estrogen and related hormone effects (13 papers) and Phytoestrogen effects and research (9 papers). William Koltun is often cited by papers focused on Menopause: Health Impacts and Treatments (15 papers), Estrogen and related hormone effects (13 papers) and Phytoestrogen effects and research (9 papers). William Koltun collaborates with scholars based in United States, Germany and Pakistan. William Koltun's co-authors include David F. Archer, David Portman, Fernand Labrie, Isabelle Côté, John Balser, Lyne Lavoie, Céline Martel, Douglas Young, Érick Moyneur and Joachim Marr and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

William Koltun

41 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Koltun United States	24	591	410	271	243	240	41	1.6k
Juan F. Gallegos‐Orozco United States	19	841 1.4×	103 0.3×	110 0.4×	708 2.9×	68 0.3×	49	2.1k
Sandro Gerli Italy	25	148 0.3×	195 0.5×	992 3.7×	143 0.6×	199 0.8×	128	2.4k
Artur Jakimiuk Poland	20	158 0.3×	155 0.4×	764 2.8×	123 0.5×	65 0.3×	92	1.6k
Virgil A. Place United States	18	765 1.3×	179 0.4×	146 0.5×	54 0.2×	68 0.3×	35	1.5k
Aydan Bırı Türkiye	19	93 0.2×	98 0.2×	154 0.6×	172 0.7×	49 0.2×	83	1.4k
Kentaro Ichioka Japan	24	113 0.2×	183 0.4×	159 0.6×	167 0.7×	25 0.1×	79	1.8k
Fang Ma China	19	138 0.2×	76 0.2×	164 0.6×	126 0.5×	42 0.2×	65	1.2k
T. Pierpoint United Kingdom	8	557 0.9×	97 0.2×	983 3.6×	301 1.2×	36 0.1×	9	1.9k
Punith Kempegowda United Kingdom	15	452 0.8×	154 0.4×	356 1.3×	146 0.6×	24 0.1×	78	1.0k
Finn Friis Lauszus Denmark	21	269 0.5×	52 0.1×	324 1.2×	86 0.4×	34 0.1×	116	1.3k

Countries citing papers authored by William Koltun

Since Specialization

Citations

This map shows the geographic impact of William Koltun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Koltun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Koltun more than expected).

Fields of papers citing papers by William Koltun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Koltun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Koltun. The network helps show where William Koltun may publish in the future.

Co-authorship network of co-authors of William Koltun

This figure shows the co-authorship network connecting the top 25 collaborators of William Koltun. A scholar is included among the top collaborators of William Koltun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Koltun. William Koltun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Labrie, Fernand, David F. Archer, William Koltun, et al.. (2018). Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause The Journal of The North American Menopause Society. 25(11). 1339–1353. 68 indexed citations

Wagoner, Nicholas Van, Kenneth H. Fife, Peter A. Leone, et al.. (2018). Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial. The Journal of Infectious Diseases. 218(12). 1890–1899. 31 indexed citations

Miner, Philip B., William Koltun, Gregory Wiener, et al.. (2017). A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation. The American Journal of Gastroenterology. 112(4). 613–621. 99 indexed citations

Tagliaferri, Mary, et al.. (2016). A Selective Estrogen Receptor Beta Agonist for the Treatment of Hot Flushes: Phase 2 Clinical Trial. The Journal of Alternative and Complementary Medicine. 22(9). 722–728. 10 indexed citations

Labrie, Fernand, David F. Archer, William Koltun, et al.. (2016). Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause The Journal of The North American Menopause Society. 23(3). 243–256. 168 indexed citations

Miner, Philip B., et al.. (2016). Sa1440 A Phase III Study of the Efficacy and Safety of Plecanatide in the Treatment of Chronic Idiopathic Constipation (CIC) (Study-00). Gastroenterology. 150(4). S316–S316. 1 indexed citations

Labrie, Fernand, Leonard R. Derogatis, David F. Archer, et al.. (2015). Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy. The Journal of Sexual Medicine. 12(12). 2401–2412. 69 indexed citations

Archer, David F., Fernand Labrie, Céline Bouchard, et al.. (2015). Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone). Menopause The Journal of The North American Menopause Society. 22(9). 950–963. 70 indexed citations

Portman, David, Fernand Labrie, David F. Archer, et al.. (2015). Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women. Menopause The Journal of The North American Menopause Society. 22(12). 1289–1295. 56 indexed citations

10.

Geisler, William M., Judy S. Mathew, William Koltun, et al.. (2014). Randomized, Double-Blind, Multicenter Safety and Efficacy Study of Rifalazil Compared with Azithromycin for Treatment of Uncomplicated Genital Chlamydia trachomatis Infection in Women. Antimicrobial Agents and Chemotherapy. 58(7). 4014–4019. 10 indexed citations

11.

Archer, David F., et al.. (2013). Norethindrone Acetate 1.0 Milligram and Ethinyl Estradiol 10 Micrograms as an Ultra Low-Dose Oral Contraceptive. Obstetrics and Gynecology. 122(3). 601–607. 25 indexed citations

12.

Kaplan, Steven A., et al.. (2012). Solifenacin Plus Tamsulosin Combination Treatment in Men With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction: A Randomized Controlled Trial. European Urology. 63(1). 158–165. 67 indexed citations

13.

Koltun, William, Jennifer Maloney, Joachim Marr, & Michael Kunz. (2011). Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 155(2). 171–175. 29 indexed citations

14.

Ackerman, Ronald, et al.. (2010). Estradiol gel 0.1% relieves vasomotor symptoms independent of age, ovarian status, or uterine status. Menopause The Journal of The North American Menopause Society. 17(6). 1167–1173. 3 indexed citations

15.

Ackerman, Ronald, et al.. (2009). Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women. Menopause The Journal of The North American Menopause Society. 16(1). 132–140. 25 indexed citations

16.

Grady, Deborah, George F. Sawaya, Karen Johnson, et al.. (2009). MF101, a selective estrogen receptor β modulator for the treatment of menopausal hot flushes. Menopause The Journal of The North American Menopause Society. 16(3). 458–465. 50 indexed citations

17.

Tyring, Stephen K., et al.. (2008). Single‐Day, Patient‐Initiated Famciclovir Therapy versus 3‐Day Valacyclovir Regimen for Recurrent Genital Herpes: A Randomized, Double‐Blind, Comparative Trial. Clinical Infectious Diseases. 47(5). 651–658. 24 indexed citations

18.

Reindollar, Richard H., William Koltun, Anna K. Parsons, et al.. (2002). Effects of oral raloxifene on serum estradiol levels and other markers of estrogenicity. Fertility and Sterility. 78(3). 469–472. 15 indexed citations

19.

Valenzuela, Guillermo J., Luis Sanchez‐Ramos, Roberto Romero, et al.. (2000). Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. American Journal of Obstetrics and Gynecology. 182(5). 1184–1190. 112 indexed citations

20.

Roy, Subir, et al.. (1998). Treatment of acute gynecologic infections with trovafloxacin. The American Journal of Surgery. 176(6). 67S–73S. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact